02413     2200313   4500001002100000005001500021035002000036008004100056020001800097041000800115082001000123084001400133100006400147245010500211260004500316300003800361500002600399520142500425650003301850650001701883700002201900700002101922990002601943990002601969990002601995990002602021990002602047990002602073INLIS00000000000310820221112091324  a0010-0520003108221112                |          | eng    a9780123706249  aeng  a616.8  a616.8 DRU0 aDrugs and the Future : Brain Science, Addiction and Society1 aDrugs and the Future : Brain Science, Addiction and Society /cScientific Coordinators by David Nutt  aOxford :bElsevier Academic Press,c2007  axiii, 598 p. :b: illus. ;c27 cm  aIndeks : p. 567 - 598  aThe use of psychotropics drugs to modify sensation, perception, mood and behaviour has been ubiquitous in human societies since time immemorial. The scientific development of safe and effective psychotropic drugs for the treatment of psychiatric and neurological disorder is, a relatively recent phenomenon and raises several pressing questions. Will new drugs be developed for pleasure as well as medical treatment? Will new treatments for addiction itself become feasible? Will drugs emerge that can enhance cognition, and what are the ethical implications if they become widespread in society? How have previous generations coped with innovation in drugs? Will new drugs be developed to treat behavioural addictions such as gambling? How can we make the most of our new knowledge and minimise the problems it might bring?. This book explores how the knowledge gained from recent advances will be used in coming decades. Constributors cover the full range of disciplines which can provide insight into the future of addiction, from genetics to humanities. They were gathered together by the UK government's office of science and innovation to consider these issues in a unique and multi-faceted collaboration. It will be of value to neuroscientists and other biologists, to social scientist with an interest in health and drugs, to policy-makers involved in health, drugs and crime, and to the pharmaceutical industry. 4aDrugs - Physiological effect 4aDrug addicts0 aTrevor W. Robbins0 aGerald V.Stimson  a11342/MKRI-P/XII-2008  a11343/MKRI-P/XII-2008  a11343/MKRI-P/XII-2008  a11342/MKRI-P/XII-2008  a11342/MKRI-P/XII-2008  a11343/MKRI-P/XII-2008